You are here

Pivotal Therapeutics Inc.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
PVO
CSE Index: 
Currency: 

Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® is available in the US by prescription only and OMAZEN™ is available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.

Home › Listings › Life Sciences › Pivotal Therapeutics Inc.

Pivotal Therapeutics Inc. (PVO)

(%)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Company Info

Address
81 Zenway Blvd Unit 10
Woodbridge, ON L4H 0S5
Canada
Phone
1-905-8569797
Fax
1-905-8562177
Email
EBortoluzzi@pivotaltherapeutics.us
Website
http://www.pivotaltherapeutics.us
Listing date
Thursday, May 19, 2011
Investor Relations
Pivotal Therapeutics Inc.
Auditor
MNP LLP.

SEDAR Information

Filing Type Any
Timeframe 1 week1 month3 month6 month1 yearAll Time

Search form

Company Info

Address
81 Zenway Blvd Unit 10
Woodbridge, ON L4H 0S5
Canada
Phone
1-905-8569797
Fax
1-905-8562177
Email
EBortoluzzi@pivotaltherapeutics.us
Website
http://www.pivotaltherapeutics.us
Listing date
Thursday, May 19, 2011
Investor Relations
Pivotal Therapeutics Inc.
Auditor
MNP LLP.

Capitalization

Issued & Outstanding: 
96566669
Reserved for Issuance: 
10680384

News Releases

02/12/2016

Pivotal Therapeutics Inc. Receives Statement of Claim and Files Statement of Defence and Counterclaim Against Crossover Healthcare Fund, LLC

06/05/2016

PIVOTAL ANNOUNCES CEASE TRADE ORDERS AND PROVIDES CORPORATE UPDATE

Bulletins

23/10/2017

2017-1012 - Delist - Pivotal Therapeutics Inc. (PVO)

October 23, 2017

The common shares of Pivotal Therapeutics Inc. will be delisted at the market close today, October 23, 2017. 

Pivotal Therapeutics is currently suspended. 

Date: Market close, October 23, 2017
Symbol: PVO

CSE Filings

Monthly Progress Report-January 2016

Monthly Progress Report - December 2015

Monthly Progress Report - November 2015

Q3 2015 - Quarterly Listing Statement

Form 9 - November 6, 2015